These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31996060)

  • 21. [Anti-beta 2 glycoprotein 1 antibodies in idiopathic livedo reticularis].
    Aubry F; Crickx B; Nicaise P; Labarre C; Viard JP; Belaïch S
    Ann Dermatol Venereol; 1995; 122(10):667-70. PubMed ID: 8687049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Livedo racemosa in neurological diseases: an update on the differential diagnoses.
    Mitri F; Enk A; Bersano A; Kraemer M
    Eur J Neurol; 2020 Oct; 27(10):1832-1843. PubMed ID: 32526049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic livedo racemosa presenting with splenomegaly and diffuse lymphadenopathy.
    Bukavina L; Weaver J; Nagy T; Brodell RT; Mostow EN
    Cutis; 2016 Oct; 98(4):E26-E29. PubMed ID: 27874892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Livedoid vasculopathy: thrombotic or inflammatory disease?
    Khenifer S; Thomas L; Balme B; Dalle S
    Clin Exp Dermatol; 2010 Oct; 35(7):693-8. PubMed ID: 19874344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Livedo Racemosa - The Pathophysiology of Decompression-Associated Cutis Marmorata and Right/Left Shunt.
    Hartig F; Reider N; Sojer M; Hammer A; Ploner T; Muth CM; Tilg H; Köhler A
    Front Physiol; 2020; 11():994. PubMed ID: 33013436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and histological characteristics of livedo racemosa in essential thrombocythemia: A report of two cases and review of the published works.
    Inoue S; Okiyama N; Okune M; Shiraki N; Kessoku R; Fujimoto M
    J Dermatol; 2017 Jan; 44(1):84-87. PubMed ID: 27570091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sneddon's syndrome (livedo reticularis and cerebral thrombosis) with livedo vasculitis and anticardiolipin antibodies.
    Grattan CE; Burton JL; Boon AP
    Br J Dermatol; 1989 Mar; 120(3):441-7. PubMed ID: 2636849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sneddon Syndrome: A Comprehensive Overview.
    Samanta D; Cobb S; Arya K
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2098-2108. PubMed ID: 31160219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterotopic ossification of small saphenous vein and panniculitis ossificans of chronic venous insufficiency presenting with livedo racemosa.
    Lekich C; Parsi K
    Phlebology; 2014 Jul; 29(6):401-6. PubMed ID: 23846577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cutaneous alterations in vasculitides : Part 2: Special aspects of diseases of large, medium and small vessels].
    Sunderkötter C; Michl C
    Internist (Berl); 2019 Aug; 60(8):805-813. PubMed ID: 31300830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Livedo racemosa: a report of five cases.
    Zala L; Braathen LR
    Dermatology; 1994; 189(4):421-4. PubMed ID: 7873835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Livedoid vasculopathy and recurrent thrombosis in a patient with lupus: seronegative antiphospholipid syndrome?
    Sopeña B; Pérez-Rodríguez MT; Rivera A; Ortiz-Rey JA; Lamas J; Freire-Dapena MC
    Lupus; 2010 Oct; 19(11):1340-3. PubMed ID: 20659971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Livedo reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus.
    Weinstein C; Miller MH; Axtens R; Buchanan R; Littlejohn GO
    Arch Dermatol; 1987 May; 123(5):596-600. PubMed ID: 3579340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early-onset stroke, polyarteritis nodosa (PAN), and livedo racemosa.
    Pichard DC; Ombrello AK; Hoffmann P; Stone DL; Cowen EW
    J Am Acad Dermatol; 2016 Aug; 75(2):449-53. PubMed ID: 27444081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of kidney disease in Sneddon's syndrome: Case report and literature review
.
    Ghislain L; Aydin S; Marot L; Demoulin N; Morelle J
    Clin Nephrol; 2020 Apr; 93(4):209-214. PubMed ID: 31661059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Livedo racemosa generalisata and stroke.
    de Reus R; de Reuck J; Vermander F; de Keyser H; Kint A; van de Velde E
    Clin Neurol Neurosurg; 1985; 87(2):143-8. PubMed ID: 4028592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and immunologic features of livedo reticularis in lupus: a case-control study.
    Englert HJ; Loizou S; Derue GG; Walport MJ; Hughes GR
    Am J Med; 1989 Oct; 87(4):408-10. PubMed ID: 2801732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis and treatment of livedo reticularis on the legs].
    Herrero C; Guilabert A; Mascaró-Galy JM
    Actas Dermosifiliogr; 2008 Oct; 99(8):598-607. PubMed ID: 19080891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Macular lymphocytic arteritis and periarteritis nodosa: A case report showing diagnostic and nosological challenges posed by these two entities].
    Taconet S; Vignon-Pennamen MD; Fouchard N
    Ann Dermatol Venereol; 2015 Oct; 142(10):567-71. PubMed ID: 26372546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sneddon's syndrome and systemic lupus erythematosus with cerebrovascular disturbances and widespread livedo].
    Kalashnikova LA; Dobrynina LA; Reshetniak TM; Aleksandrova EA; Lozhnikova SM; Gulevskaia TS; Nasonov EL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(7):21-5. PubMed ID: 16117142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.